Streetbeat News

Earnings

OLO

Olo (NYSE:OLO) reported its Q4 earnings with an EPS of $0.05, meeting the estimate. Revenue increased by $13.22 million from the previous year. Despite meeting EPS estimates this quarter, a miss in the last quarter led to a 25.64% share price drop the following day. Olo's revenue has consistently exceeded estimates over the past four quarters.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 9:25 pm

VMI

Valmont Industries (NYSE:VMI) reported Q4 earnings with an EPS of $3.18, beating estimates by 4.61% but with a revenue decrease of $115.52 million from the previous year. Despite beating EPS estimates in past quarters, such performance previously led to a 13.95% drop in share price the following day.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 9:25 pm

OM

Outset Medical (NASDAQ:OM) reported Q4 earnings with an EPS of $-0.59, beating estimates by 3.28% but with a revenue decrease of $1.50 million from the previous year. The company's past earnings performance shows a pattern of mixed results, with the last quarter's miss on EPS followed by a 14.39% drop in share price.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 9:25 pm

FNF

Fidelity National Financial (NYSE:FNF) reported Q4 earnings with an EPS of $0.75, missing estimates by 25.0% against an expected $1.0. Revenue increased by $879.00 million from the same period last year. In the previous quarter, FNF beat EPS estimates by $0.1, leading to a 3.41% share price increase the following day. The company's past earnings performance shows mixed results with both beats and misses in EPS and revenue against estimates.

Portfolio Pulse from Benzinga Insights

February 21, 2024 | 9:25 pm

ACVA

ACV Auctions' stock price increased following the announcement of its Q4 financial results, which exceeded expectations. Additionally, the company has settled its antitrust litigation concerning the AutoIMS technology platform.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 9:24 pm

OM

Outset Medical (OM) reported Q4 2023 adjusted EPS of $(0.59), surpassing the $(0.61) estimate. Sales reached $30.51M, slightly above the $30.40M estimate but marked a 4.69% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 9:24 pm

NVDA

NVIDIA's Q4 earnings report shows significant growth in several key areas. Data Center revenue soared to $18.4 billion, marking a 409% increase year-over-year. Gaming revenue also saw a substantial rise, reaching $2.9 billion with a 56% increase YoY. Professional Visualization revenue doubled to $463 million, up 105% YoY. However, Automotive revenue slightly declined by 4% YoY to $281 million.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 9:24 pm

RIVN

Rivian's stock price declined following the release of mixed financial results for the fourth quarter. The company's performance during this period did not fully meet investor expectations, leading to a decrease in share value.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 9:23 pm

NVDA

Nvidia reported a significant decline in data center sales to China in the fourth quarter, attributing the downturn to U.S. government licensing requirements.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 9:23 pm

NVDA

Nvidia has projected its GAAP and Non-GAAP Other Income and Expense to be $250M for Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 9:23 pm